Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Defective Stem Cell Behavior Linked to Psoriasison December 14, 2019 at 5:22 am
More treatments are needed for the 100 million individuals worldwide affected by psoriasis. Researchers from Brigham and Women's Hospital and the Harvard Stem Cell Institute have discovered a possible ...
- California stem cell company halts sales after FDA warningon December 13, 2019 at 10:47 am
A California stem cell company on Friday announced the immediate suspension of sales of umbilical cord blood-derived products, a week after federal regulators said the treatments were unapproved drugs ...
- Micro-RNAs keep stem cells from growing up too faston December 13, 2019 at 5:34 am
There comes a point in every cell's life when it has to decide what it wants to be when it grows up. Young cells, so-called stem cells, take their clues to their future career primarily from the ...
- Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapyon December 13, 2019 at 2:18 am
Herein using Rap1 null mice, we provide the genetic evidence that mammalian Rap1 plays a major role in hematopoietic stem cell survival, oncogenesis and response to chemotherapy. Strikingly, this ...
- Rogue stem-cell salesman Davide Vannoni dieson December 12, 2019 at 8:32 am
The disgraced stem-cell entrepreneur Davide Vannoni, who in the past decade treated hundreds of people in Italy with an unproven treatment that health authorities considered ineffective and ...
- Targeting stem cells that drive aggressive blood canceron December 12, 2019 at 4:50 am
They identified a new druggable target in AML stem cells, which are the 'roots' that sustain this type of cancer. Although these stem cells are rare, they are likely to be the main cause for ...
- Local teen hoping to find stem cell transplant match through Be the Match bone marrow registryon December 11, 2019 at 2:33 pm
ABINGTON, Pennsylvania (WPVI) -- A local teenager in need of a life-saving stem cell transplant is encouraging more people, especially minorities, to join the bone marrow registry. Juwan Adams, 17, ...
- Epithelial Stem Cells (Escs) Market Advancement Strategy, world Top Players, Analysis and Forecast To 2026on December 11, 2019 at 10:03 am
Dec 11, 2019 (Market Research Analyst via COMTEX) -- The recent research report on the global Epithelial Stem Cells (Escs) Market presents the latest industry data and future trends, allowing you to ...
- Epithelial Stem Cells (Escs) Industry 2026 Deep Market Research Reporton December 11, 2019 at 9:24 am
Dec 11, 2019 (Hitech News Daily via COMTEX) -- The recent research report on the global Epithelial Stem Cells (Escs) Market presents the latest industry data and future trends, allowing you to ...
- Weaponizing stem cells in the war on diabeteson December 11, 2019 at 6:54 am
"Although current diabetes medication can help to control blood glucose levels for extended periods of time, they do not cure or even improve pancreatic beta cell health." This is why Teo's team sees ...
via Bing News